Verseon Acquires Edammo
October 18, 2022
Verseon International Corporation, a Fremont, California–based drug-discovery company, has acquired Edammo, Inc. to integrate Edammo's Extreme AutoML technology into Verseon's physics-augmented AI drug-discovery platform. The acquisition is intended to strengthen Verseon's machine‑learning capabilities for small, sparse life‑sciences datasets and accelerate drug candidate discovery.
- Buyers
- Verseon International Corporation
- Targets
- Edammo, Inc.
- Industry
- AI & Machine Learning
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Voiant Acquires Voxeleron
August 2, 2025
AI & Machine Learning
Voiant has acquired Voxeleron, an AI-driven ophthalmic image analysis company, to integrate advanced AI/ML imaging capabilities into its clinical trial imaging platform. The deal combines Voiant’s clinical trial imaging expertise with Voxeleron’s cloud-based image analysis tools to accelerate biomarker development, improve data accuracy, and enhance ophthalmology-focused clinical research services.
-
Exiger Acquires Versed AI
July 8, 2024
AI & Machine Learning
Exiger, a supply chain and third-party risk AI company, has acquired Versed AI, a Cambridge University spin-out that uses AI and NLP to map multi-tier supplier networks and generate automated bills of material. The acquisition integrates Versed AI's capabilities into Exiger's supply chain platform to expand multi-tier visibility and accelerate product-specific supply chain mapping for Exiger customers.
-
Agilent Technologies Acquires Avida Biomed
January 4, 2023
Biotechnology
Agilent Technologies has acquired Avida Biomed, an early-stage developer of high-performance NGS target enrichment workflows for cancer research. The acquisition augments Agilent's SureSelect portfolio and expands its capabilities into high-growth clinical research and diagnostics markets by adding Avida's chemistries and automatable assays compatible with Agilent platforms.
-
OpenEvidence Acquires AI Advertising Startup Amaro
September 10, 2025
Marketing & Advertising
OpenEvidence has acquired Amaro, an AI-native advertising startup founded by Kush and Sauren Khosla and backed by Google Ventures and Greycroft. The deal brings Amaro's team and ad-optimization technology into OpenEvidence to expand its advertising infrastructure and accelerate monetization while scaling its clinical AI platform.
-
Science & Medicine Group Acquires Amplion
September 7, 2022
Data & Analytics
Science & Medicine Group (SMG), a data intelligence company based in Arlington, Virginia, acquired the assets of Amplion Inc., an AI-powered data intelligence platform for life-science commercial teams. The acquisition integrates Amplion’s knowledgebase and machine-learning capabilities into SMG’s portfolio to expand its commercial data and targeting capabilities for pharmaceutical, biotech and academic customers.
-
VisiQuate Acquires Etyon
July 1, 2025
Healthcare Services
VisiQuate, an AI-driven revenue cycle management (RCM) provider, has acquired Etyon, a Milwaukee-based healthcare technology firm specializing in RCM machine learning, denial prevention algorithms, and data tokenization. The deal is intended to expand VisiQuate’s ML and data capabilities within its Ana Intelligence Suite to deliver deeper predictive insights and improved denials and payments management for healthcare providers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.